nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
您当前所在位置: 首页> 文献列表> 卵泡期长效长方案在高龄女性中的运用分析
2021, 01, v.30 19-24
卵泡期长效长方案在高龄女性中的运用分析
基金项目(Foundation): 福建省自然科学基金项目(2019J05137); 福建省卫生健康科技计划项目(2019-ZQN-22)
邮箱(Email): ;
DOI:
投稿时间: 2020-07-12
投稿日期(年): 2020
修回时间: 2020-08-07
终审时间: 2020-12-03
终审日期(年): 2020
审稿周期(年): 1
发布时间: 2021-01-15
出版时间: 2021-01-15
移动端阅读
摘要:

目的探究在高龄女性中,卵泡期长效长方案控制性卵巢刺激(COS)的临床结局及影响临床妊娠和卵巢反应的关键因素。方法回顾性分析行卵泡期长效长方案COS的411例高龄(35~44岁)女性的临床资料。运用Logistic回归筛选每移植周期临床妊娠及卵巢低反应的独立影响因素。运用受试者工作特征(ROC)曲线下面积(AUC)评估各独立影响因素的预测准确度。结果所纳入患者的基础AMH值介于0.25~14.51 ng/ml,平均(3.23±2.21)ng/ml。35~39岁患者每移植周期临床妊娠率39.02%~55.00%。40岁及以上患者每移植周期临床妊娠率为16.67%(5/30)。当基础AMH≤1.0 ng/ml时,卵巢低反应的发生率为56.52%(13/23);基础AMH>1.5 ng/ml时,卵巢低反应的发生率为4.76%(16/336)。Logistic回归显示,年龄[OR=0.777,95%CI(0.654,0.923)]、BMI [OR=0.858,95%CI(0.753,0.977)]、HCG日LH水平[OR=0.690,95%CI(0.485,0.982)]是每移植周期临床妊娠的独立影响因素(P<0.05)。ROC曲线分析显示年龄、BMI、HCG日LH水平预测每移植周期临床妊娠的AUC分别为0.540、0.571、0.528。另外,基础AMH是卵巢低反应的唯一独立影响因素[OR=0.359,95%CI(0.213,0.603)](P<0.001),其预测卵巢低反应的AUC为0.831。结论在运用卵泡期长效长方案COS的卵巢储备功能尚可的高龄女性中,35~39岁患者的每移植周期临床妊娠率较理想;体重控制及COS过程中LH水平的控制有助提高每移植周期临床妊娠率;基础AMH是卵巢低反应的唯一独立影响因素,可有效预测卵巢低反应。

Abstract:

Objective:To explore the clinical outcome of controlled ovarian stimulation(COS) and the key factors affecting clinical pregnancy and ovarian response in the long-acting GnRH agonist long protocol in follicular phase.Methods:The data of 411 elder women(35-44 years) administered with long-acting GnRH agonist long protocol were retrospectively analyzed. Logistic regression was applied to identify the independent risk factors of clinical pregnancy rate per transfer cycle and poor ovarian response. The prediction accuracy of the independent risk factors was evaluated by calculating the area under the receiver operating characteristic(ROC) standard curve(AUC).Results:Baseline AMH levels in included patients were between 0.25 ng/ml and 14.51 ng/ml,and mean±SD of which was(3.23±2.21) ng/ml. The clinical pregnancy rate per transfer cycle was between 39.02% and 55.00% in women aged 35 to 39. The clinical pregnancy rate per transfer cycle was 16.67%(5/30) in women aged ≥40. In patients with AMH level ≤1.0 ng/ml,the rate of poor ovarian response was 56.52%(13/23). In patients with AMH level >1.5 ng/ml,the rate of poor ovarian response was 4.76%(16/336). Multivariate logistic regression analysis showed that age [OR=0.777,95%CI(0.654,0.923)],BMI [OR=0.858,95%CI(0.753,0.977)],LH level on HCG day [OR=0.690,95%CI(0.485,0.982)] were independent affecting factors of the clinical pregnancy rate per transfer cycle(P<0.05). ROC curve analysis showed that AUC for predicted the clinical pregnancy rate per transplant cycle by age,BMI,and LH level on HCG day was 0.540,0.571 and 0.528,respectively. In addition,basic AMH was the only independent influencing factor of ovarian hypo-responsiveness [OR=0.359,95%CI(0.213,0.603)](P<0.001),and its AUC for predicting ovarian hypo-responsiveness was 0.831.Conclusions:Administration of long-acting GnRH agonist long protocol in women aged 35 to 39 can achieve good outcomes of clinical pregnancy per transfer cycle. Controlling weight and LH level during COS can improve the pregnancy rate per transfer cycle. Baseline AMH is only independent risk factor for poor ovarian response,which can effectively predict low ovarian response.

参考文献

[1] 蒋励,陈耀龙,罗旭飞,等.中国高龄不孕女性辅助生殖临床实践指南[J].中国循证医学杂志,2019,19:253-270.

[2] Revel A.Defective endometrial receptivity[J].Fertil Steril,2012,97:1028-1032.

[3] Johnson JA,Tough S,SOGC Genetics Committee.Delayed child-bearing [J].J Obstet Gynaecol Can,2012,34:80-93.

[4] 陈彩虹,郭艺红.卵泡期长效长方案促排卵早期思考[J].生殖医学杂志,2019,28:1130-1132.

[5] 李娜,师娟子.为什么降调节方案仍是国内首选促排卵方案?[J].生殖医学杂志,2017,26:1063-1066.

[6] 乔杰,马彩虹,刘嘉茵,等.辅助生殖促排卵药物治疗专家共识[J].中华生殖与避孕杂志,2015,35:211-223.

[7] La Marck A,Sunkara SK.Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers:from theory to practice [J].Hum Reprod Update,2014,20:124-140.

[8] Mourad S,Brown J,Farguhar C.Interventions for the prevention of OHSS in ART cycles:an overview of Cochrane reviews[DB/OL].Cochrane Database Sys Rev,2017,(1):CD012103.

[9] 胡琳莉,黄国宁,孙海翔,等.辅助生殖技术临床关键指标质控专家共识[J].生殖医学杂志,2018,29:828-835.

[10] Sneed ML,Uhler ML,Grotjan HE,et al.Body mass index:impact on IVF success appears age-related [J].Hum Reprod,2008,23:1835-1839.

[11] DeUgarte DA,DeUgarte CM,Sahakian V.Surrogate obesity negatively impacts pregnancy rates in third-party reproduction [J].Fertil Steril,2010,93:1008-1010.

[12] 郑琪珍,莫美兰,王丝丝,等.控制性促排卵中特殊人群添加重组人黄体生成素的临床应用[J].生殖医学杂志,2019,28:95-99.

[13] 孙梅,崔文娟.影响生育力的因素及高龄生育的策略[J].山东大学学报(医学版),2019,57:23-28.

[14] Drakopoulos P,Blockeel C,Stoop D,et al.Conventional ovarian stimulation and single embryo transfer for IVF/ICSI.How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?[J].Hum Reprod,2016,31:370-376.

[15] Unkara SK,Rittenberg V,Raine-Fenning N,et al.Association between the number of eggs and live birth in IVF treatment:an analysis of 400 135 treatment cycles [J].Hum Reprod,2011,26:1768-1774.

[16] Toftager M,Bogstad J,L?ssl K,et al.Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women:Secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols [J].Hum Reprod,2017,32:556-567.

[17] Steiner AZ,Pritchard D,Stanczyk FZ,et al.Association between biomarkers of ovarian reserve and infertility among older women of reproductive age[J].JAMA,2017,318:1367-1376.

基本信息:

中图分类号:R714.8

引用信息:

[1]柯张红,郑备红,孙艳,等.卵泡期长效长方案在高龄女性中的运用分析[J].生殖医学杂志,2021,30(01):19-24.

基金信息:

福建省自然科学基金项目(2019J05137); 福建省卫生健康科技计划项目(2019-ZQN-22)

投稿时间:

2020-07-12

投稿日期(年):

2020

修回时间:

2020-08-07

终审时间:

2020-12-03

终审日期(年):

2020

审稿周期(年):

1

发布时间:

2021-01-15

出版时间:

2021-01-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文